CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 250 enrolled
Drug / intervention
modified light transmission intraocular lens +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00747227
NCT00747227Phase 3Completed
CompareCT.gov

Clinical Evaluation of a Modified Light Transmission IOL

Abbott Medical Optics·interventional·Posted Sep 5, 2008·Updated Nov 11, 2011

In Brief

A Phase 3 clinical trial evaluating modified light transmission intraocular lens and monofocal acrylic intraocular lens for Cataract. Completed, enrolled 250 participants across 11 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 5, 2008
Enrollment StartDec 1, 2006
Primary CompletionMar 1, 2009
Study CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.8 years ago

Interventions

modified light transmission intraocular lensdevice

violet visible light blocking acrylic intraocular lens

monofocal acrylic intraocular lensdevice

conventional hydrophobic acrylic intraocular lens